Currently there are conflicting results regarding optic neuropathy in diabetes mellitus. Therefore, the aim of the present study was to evaluate optic neuropathy in diabetic patients. We studied visual evoked potentials (VEPs) in 20 diabetic patients (6 insulin dependent, 14 noninsulin dependent; 8 women, 12 men; mean age: 49.70± 18.22 years; mean duration of diabetes: 9.33 ± 5.75 years) and 20 age-, and sex-matched healthy subjects (7 women, 13 men; mean age: 52.40 ± 16.02 years) as a control group. Nine of 20 diabetic patients had sensorimotor neuropathy, and 5 diabetic patients had both sensorimotor neuropathy and autonomic neuropathy, as well as 3 diabetic patients had diabetic retinopathy. P 100 wave latency was significantly longer in diabetic patients than those of the control group (p

Currently there are conflicting results regarding optic neuropathy in diabetes mellitus. Therefore, the aim of the present study was to evaluate optic neuropathy in diabetic patients. We studied visual evoked potentials (VEPs) in 20 diabetic patients (6 insulin dependent, 14 noninsulin dependent; 8 women, 12 men; mean age: 49.70± 18.22 years; mean duration of diabetes: 9.33 ± 5.75 years) and 20 age-, and sex-matched healthy subjects (7 women, 13 men; mean age: 52.40 ± 16.02 years) as a control group. Nine of 20 diabetic patients had sensorimotor neuropathy, and 5 diabetic patients had both sensorimotor neuropathy and autonomic neuropathy, as well as 3 diabetic patients had diabetic retinopathy. P 100 wave latency was significantly longer in diabetic patients than those of the control group (p